PBDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protalix Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 2.115 EUR 2.92%

Market Cap: €155.1m

	Protalix Biotherapeutics Inc F:PBDA	US
D	DSM-Firmenich AG OTC:DSMFF	CH
O	Occidental Petroleum Corp XBER:OPC	US
L	LY Corp XMUN:YOJ	JP
C	China Citic Bank Corp Ltd XMUN:D7C	CN
C	China Mobile Ltd XMUN:CTM	CN
W	Westlake Corp F:UEO	US
Y	Yankuang Energy Group Co Ltd XMUN:YZCA	CN
C	CNH Industrial NV XMUN:37C	UK
	Mauna Kea Technologies SA F:1MK	FR
E	Extreme Networks Inc F:EXM	US
T	Takeda Pharmaceutical Co Ltd F:TKDA	JP

Profitability Summary

Protalix Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

72% > 49%

Negative Operating Margin

-10%

Low 3Y Average Operating Margin

Declining Operating Margin

18% > -10%

Negative Net Margin

-13%

Low 3Y Average Net Margin

Declining Net Margin

13% > -13%

Negative Free Cash Flow Margin

-26%

Negative 3Y Average Free Cash Flow Margin

-5%

Declining Free Cash Flow Margin

-16% > -26%

Negative ROE

-14%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.